We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCEC
11501
PUT
Capital Clean Energy Carriers
CCEC
$1.34B
-48,300
Closed -$319K
ORKA
11502
Oruka Therapeutics
ORKA
$5.82B
-848
Closed -$45K
ABFL
11503
Abacus FCF Leaders ETF
ABFL
$520M
-31,059
Closed -$1.28M
RNTX
11504
Rein Therapeutics
RNTX
$63.1M
-2,153
Closed -$56K
RDGT
11505
Ridgetech Inc
RDGT
$2.74M
-3
Closed -$92K
KLRS
11506
Kalaris Therapeutics
KLRS
$83.5M
-1,674
Closed -$1.06M
EQC
11507
CALL
DELISTED
Equity Commonwealth
EQC
-54,800
Closed -$1.46M
ATSG
11508
DELISTED
Air Transport Services Group
ATSG
-34,411
Closed -$1M
VOXX
11509
DELISTED
VOXX International Corporation Class A
VOXX
-10,133
Closed -$118K
VOXX
11510
PUT
DELISTED
VOXX International Corporation Class A
VOXX
-17,800
Closed -$137K
PTVE
11511
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
-19,507
Closed -$248K
UTRN
11512
DELISTED
Vesper US Large Cap Short-Term Reversal Strategy ETF
UTRN
-20,871
Closed -$608K
BACK
11513
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
-656
Closed -$15K
CUTR
11514
CALL
DELISTED
Cutera, Inc.
CUTR
-11,800
Closed -$224K
CDMO
11515
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-10,300
Closed -$78K
CDMO
11516
PUT
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-20,700
Closed -$158K
B
11517
PUT
DELISTED
Barnes Group Inc.
B
-5,700
Closed -$204K
PSTX
11518
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-44,515
Closed -$395K
MSVX
11519
DELISTED
LHA Market State Alpha Seeker ETF
MSVX
-17,653
Closed -$428K
BSJO
11520
DELISTED
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
-65,646
Closed -$1.58M
PRMW
11521
CALL
DELISTED
Primo Water Corporation
PRMW
-28,200
Closed -$400K
VGR
11522
PUT
DELISTED
Vector Group Ltd.
VGR
-49,632
Closed -$341K
EGRX
11523
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-13,800
Closed -$586K
KA
11524
CALL
DELISTED
Kineta, Inc. Common Stock
KA
-124
Closed -$19K
KA
11525
DELISTED
Kineta, Inc. Common Stock
KA
-221
Closed -$34K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.